Repetitive magnetic stimulation or sham for OCD
About this title
rTMS in Treatment of Obsessive Compulsive Disorder (OCD)
Read the official source — NCT00616486This study evaluated the safety and effectiveness of transcranial magnetic stimulation for people with OCD.
Understand this study
What did researchers investigate?
This study evaluated the safety and effectiveness of transcranial magnetic stimulation for people with OCD.
Who was this study for?
This study was for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Sofia and 2 more locationsSee all locations and recruitment
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 24
- Sponsor
- Queen's University
- Sponsor type
- University
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- Canada, Bulgaria, Türkiye
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00616486
- Official title
Show the full official title
A Multicentre, Double-blind, Randomized, Placebo-controlled Study Evaluating the Efficacy, Safety, and Clinical Outcomes of Low Frequency, Repetitive Transcranial Magnetic Stimulation (Over Supplementary Motor Area (SMA) Applied Bilaterally and Simultaneously) Versus Sham (Placebo rTMS) Treatment for 6 Weeks, When Added to a Stable Pharmacotherapy in Subjects With Obsessive Compulsive Disorder (OCD).
Get this study by email
Recruitment & locations
CompletedSofia, Bulgaria · Kingston, Canada · Izmir, Türkiye
1 more locations
- Türkiye
Questions about this study
What did researchers investigate?
This study evaluated the safety and effectiveness of transcranial magnetic stimulation for people with OCD.
Who is behind this study?
The study sponsor is Queen's University, a university.
Who was this study for?
This study was for people with OCD. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
